Post-earnings recap
Reported
Wed, Oct 27, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Edwards Lifesciences reported a slight earnings beat for the quarter, with an EPS of $0.54. However, the stock reacted negatively, declining by 0.79%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.54 | N/A | +1.69% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.